Memorial Sloan Kettering Cancer Center (MSK) is the world's oldest and largest private institution devoted to the prevention, treatment, and cure of cancer. We have dedicated more than a century to patient care and innovative research. The Pharmacy Department at Memorial Sloan Kettering recognizes the value and need for an oncology specialty residency for pharmacists seeking a career in oncology practice.
PGY2 pharmacy residency training builds on the foundations of pharmacy practice established during Doctor of Pharmacy (Pharm.D.) education and the PGY1 pharmacy residency experience. The MSK PGY2 Oncology Pharmacy (pediatric-focused) residency provides residents with a 12 month learning experience that prepares them to function independently as a clinical pharmacy practitioner in oncology, to serve as a fully integrated member of a multi-disciplinary team, and to optimize medications used in the provision of cancer care. Residents who successfully complete a PGY2 Oncology Pharmacy (pediatric focused) residency at MSK will possess competencies that prepare them for future clinical, research or academic positions, leadership roles in oncology, and board certification in oncology pharmacy.
The pediatric oncology specialty residency provides advanced training in clinical therapeutics for the pediatric cancer patient. The main objectives of this one-year training program are to help residents:
Establish a firm knowledge base in pediatric cancer conditions, treatment options, antineoplastic pharmacology, and pharmacokinetics
Optimize outcomes in pediatric cancer patients through evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team
Foster clinical problem-solving skills
Provide an introduction to clinical research
Our 12 month program includes focused rotations in Pediatric Medical Oncology (Neuroblastoma, Sarcoma, CNS Malignancies), in Pediatric Hematologic Malignancies, and Pediatric Stem Cell Transplant. Additional rotations are available in Investigational Drug Services, Pediatric ICU, Adult Leukemia/Lymphoma, and Pain and Palliative Care. Residents will also develop skills for continuous professional development through the required completion of a pediatric oncology clinical research project, case presentations, literature evaluation, oncology didactic lectures, and education to medical and pharmacy staff. The residency program is supported by board certified pediatric oncology pharmacy preceptors, pharmacy staff and administration.
Requirements for consideration in the program include:
Completion of an ASHP accredited PGY1 residency program
Eligibility for Pharmacy licensure in NY State
Interested applicants will be required to submit through PhORCAS the following: Curriculum Vitae, Letter of Interest, Three letters of recommendation and Official Academic Transcripts.
For more information please contact the Residency Program Director: Sherry Mathew Pharm.D, BCOP Manager, Pediatric Clinical Pharmacy Services, Pediatric Oncology Residency Program Director Email: email@example.com
Memorial Sloan Kettering Cancer Center (MSK) is the world's oldest and largest private institution devoted to the prevention, treatment, and cure of cancer. We have dedicated more than a century to patient care and innovative research. The Pharmacy Department at Memorial Sloan Kettering recognizes the value and need for an American Society of Health-System Pharmacists (ASHP) accredited Post-Graduate Year 2 (PGY2) residency program for pharmacists seeking a career in adult oncology practice.